You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced Renal Cell Carcinoma (aRCC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Among Advanced Renal Cell Carcinoma Receiving Systemic

Not yet recruiting
  • Carcinoma, Renal Cell
    • (no location specified)
    Sep 6, 2022

    Collect Pre-existing Data on Administration of Cabozantinib in

    Recruiting
    • Advanced Renal Cell Carcinoma
      • Amiens, France
      • +27 more
      Dec 26, 2022

      Cabozantinib Post First-line Immuno-oncology Checkpoint

      Completed
      • Advanced Renal Cell Carcinoma (aRCC)
        • Glasgow, United Kingdom
        • +8 more
        Jun 30, 2022

        Nivolumab Plus Ipilimumab in Renal Cell Cancer in Real World

        Active, not recruiting
        • Advanced or Metastatic Renal Cell Carcinoma
          • Tokyo, Japan
            Local Institution - 0001
          May 25, 2022

          And Use Of Avelumab In Combination With Axitinib For Treatment

          Recruiting
          • Advanced Renal Cell Carcinoma
          • Sandwich, Kent, United Kingdom
            Pfizer Ltd
          May 23, 2022

          Cabozantinib in Combination With Nivolumab as First-line

          Recruiting
          • Advanced Renal Cell Carcinoma
            • Angers, France
            • +42 more
            Dec 1, 2022

            Among aRCC Patients on Cabozantinib or Axitinib in England

            Completed
            • Renal Cell Carcinoma
            • Slough, United Kingdom
              Ipsen Facility
            Jan 29, 2021

            Axitinib Dose Reduction and Interruption for Adverse Event

            Completed
            • Renal Cell Carcinoma
            • New York, New York
              Pfizer
            Sep 15, 2022

            Metastatic and/or Advanced Renal Cell Carcinoma, Treated With

            Completed
            Has Results
            • Carcinoma
            • Renal Cell
            • London, United Kingdom
              Pfizer UK
            Jan 9, 2023

            Renal Cell Carcinoma Trial in Rome (donor FMT, Placebo FMT)

            Recruiting
            • Renal Cell Carcinoma
            • donor FMT
            • Placebo FMT
            • Rome, Italy
            • +1 more
            Jul 26, 2022

            ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

            Not yet recruiting
            • ccRCC
            • +20 more
            • (no location specified)
            Jul 6, 2023

            Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

            Recruiting
            • Advanced Renal Cell Carcinoma
            • ST-1898 tablets
            • Beijing, Beijing, China
              Peking University Cancer Hospital & Institute
            Nov 6, 2023

            Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

            Recruiting
            • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
            • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
            • Shanghai, Shanghai, China
              Shanghai Renji Hospital
            Sep 12, 2023

            Renal Cell Carcinoma Trial (HS-10516)

            Not yet recruiting
            • Renal Cell Carcinoma
            • (no location specified)
            Sep 24, 2023

            Renal Cell Carcinoma Trial in Tabriz (Sodium Pentaborate)

            Not yet recruiting
            • Renal Cell Carcinoma
            • Sodium Pentaborate
            • Tabriz, East Azarbayejan, Iran, Islamic Republic of
              Imam Reza hospital and Clinic of Salamat
            Mar 23, 2023

            Renal Cell Carcinoma Trial in Houston (Tivozanib, Nivolumab)

            Not yet recruiting
            • Renal Cell Carcinoma
            • Houston, Texas
              M D Anderson Cancer Center
            Sep 19, 2023

            Renal Cell Carcinoma, First-line Treatment, Non Clear Cell Renal Cell Carcinoma Trial in Chengdu (AK104, Axitinib)

            Not yet recruiting
            • Renal Cell Carcinoma
            • +3 more
            • Chengdu, Sichuan, China
              West China Hospital
            Apr 10, 2023

            Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

            Not yet recruiting
            • Advanced Clear Cell Renal Carcinoma (Ccrcc)
            • Papillary Renal Cell Carcinoma (Prcc)
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Feb 2, 2023

            Renal Cell Carcinoma Trial in Beijing, Seoul (RO7247669, Tiragolumab, Pembrolizumab)

            Recruiting
            • Renal Cell Carcinoma
            • Beijing, China
            • +1 more
            Mar 28, 2023

            RCC, Renal Cell Carcinoma Trial in Dallas (Cabozantinib 80 MG, Cabozantinib 40Mg Tab, Nivolumab)

            Not yet recruiting
            • RCC
            • Renal Cell Carcinoma
            • Cabozantinib 80 MG
            • +2 more
            • Dallas, Texas
              UT Southwestern Medical Center
            Jul 3, 2023

            Advanced Renal Cell Carcinoma, Advanced Mesothelioma, Advanced Osteosarcoma Trial in Houston (CAR.70/IL15-transduced CB-derived

            Not yet recruiting
            • Advanced Renal Cell Carcinoma
            • +2 more
            • CAR.70/IL15-transduced CB-derived NK cells
            • +2 more
            • Houston, Texas
              M D Anderson Cancer Center
            Jan 27, 2023

            Advanced Renal Cell Carcinoma Trial (Botensilimab, Balstilimab, Ipilimumab)

            Not yet recruiting
            • Advanced Renal Cell Carcinoma
            • (no location specified)
            Jun 23, 2023

            Efficacy and Safety of Avelumab + Axitinib Combination in aRCC

            Recruiting
            • Carcinoma, Renal Cell
              • Bonheiden, Belgium
              • +77 more
              Sep 16, 2022

              Carcinoma, Renal Cell Trial in United States (Belzutifan)

              Recruiting
              • Carcinoma, Renal Cell
              • Boston, Massachusetts
              • +3 more
              Jan 27, 2023

              Fumarate Hydratase Deficient Renal Cell Carcinoma Trial (Tislelizumab, Lenvatinib)

              Not yet recruiting
              • Fumarate Hydratase Deficient Renal Cell Carcinoma
              • (no location specified)
              May 18, 2023